Zosano Pharma Corporation ZSAN
0.56 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
0.46 Day range 0.635
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 21.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
- 2 months ago 2
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.02 | -0.02 – -0.02 | -2.10 | +99.0% | 100.00K | -61.5% | 1 |
| Next quarter | -0.01 | -0.01 – -0.01 | -2.45 | +99.6% | 0 | 0.0% | 1 |
| Current year | -0.09 | -0.09 – -0.09 | -9.45 | +99.0% | 200.00K | -74.5% | 1 |
| Next year | -0.09 | -0.09 – -0.09 | -0.09 | 0.0% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 23, 2022 | BTIG | Downgrade | Buy | Neutral |
| Mar 15, 2021 | Maxim Group | Maintained | — | Buy |
| Nov 25, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 2, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 9, 2020 | H.C. Wainwright | Initiated | — | Buy |
| Mar 27, 2020 | BTIG | Maintained | — | Buy |
| Nov 15, 2019 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Apr 23, 2019 | Cantor Fitzgerald | Initiated | — | Overweight |
| Apr 17, 2019 | Maxim Group | Initiated | — | Buy |
| Jun 28, 2018 | BTIG Research | Initiated | — | Buy |
| Aug 11, 2016 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| Mar 5, 2015 | Ladenburg Thalmann | Initiated | — | Buy |
| Feb 23, 2015 | Roth Capital | Initiated | — | Buy |